Ramos-Júdez, Sandra
Giménez, Ignacio
Gumbau-Pous, Josep
Arnold-Cruañes, Lucas Stephen
Estévez, Alicia
Duncan, Neil
Funding for this research was provided by:
Ministerio de Economía y Competitividad (RTI2018-094710-R-I00)
Article History
Received: 30 November 2021
Accepted: 28 March 2022
First Online: 21 April 2022
Competing interests
: Dr I.G. is associated with the biotech company Rara Avis Biotec, S. L., which produced the recombinant gonadotropins employed in this study. Other than this, there are no patents or products in development to declare. The rest of contributing authors declare no competing interests.